[HTML][HTML] Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile …

SD Baines, MH Wilcox - Antibiotics, 2015 - mdpi.com
Clostridium difficile infection (CDI) remains a substantial burden on healthcare systems and
is likely to remain so given our reliance on antimicrobial therapies to treat bacterial …

[HTML][HTML] Clostridium difficile – From Colonization to Infection

H Schaeffler, A Breitrueck - Frontiers in microbiology, 2018 - frontiersin.org
Clostridium difficile is the most frequent cause of nosocomial antibiotic-associated diarrhea.
The incidence of C. difficile infection (CDI) has been rising worldwide with subsequent …

Tackling the recurrence of Clostridium difficile infection

N Petrosillo - Medecine et maladies infectieuses, 2018 - Elsevier
The pathogenesis of recurrent Clostridium difficile infection (CDI) is still poorly understood.
The risk of recurrence is approximately 20% after an initial CDI episode and dramatically …

Clostridium difficile 30 years on: what has, or has not, changed and why?

DN Gerding - International journal of antimicrobial agents, 2009 - Elsevier
The report of clindamycin-associated colitis in 1974 by Tedesco et al.[Ann Intern Med 81:
429–33] stimulated an intense search for the cause of this severe complication of antibiotic …

Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms

SS Banawas - BioMed research international, 2018 - Wiley Online Library
Clostridium difficile (C. difficile) is the most prevalent causative pathogen of healthcare‐
associated diarrhea. Notably, over the past 10 years, the number of Clostridium difficile …

[HTML][HTML] Microbiologic factors affecting Clostridium difficile recurrence

CH Chilton, DS Pickering, J Freeman - Clinical Microbiology and Infection, 2018 - Elsevier
Abstract Background Recurrent Clostridium difficile infection (rCDI) places a huge economic
and practical burden on healthcare facilities. Furthermore, rCDI may affect quality of life …

Novel therapies and preventative strategies for primary and recurrent Clostridium difficile infections

MG Dieterle, K Rao, VB Young - … of the New York Academy of …, 2019 - Wiley Online Library
Clostridium difficile is the leading infectious cause of antibiotic‐associated diarrhea and
colitis. C. difficile infection (CDI) places a heavy burden on the healthcare system, with …

[HTML][HTML] Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done …

AC Büchler, SK Rampini, S Stelling… - BMC infectious …, 2014 - Springer
Background Clostridium difficile infection (CDI) remains a major health problem worldwide.
Antibiotic use, in general, and clindamycin and ciprofloxacin, in particular, have been …

Antibiotic Resistances of Clostridium difficile

P Spigaglia, P Mastrantonio, F Barbanti - Updates on Clostridium difficile …, 2018 - Springer
The rapid evolution of antibiotic resistance in Clostridium difficile and the consequent effects
on prevention and treatment of C. difficile infections (CDIs) are matter of concern for public …

Recurrent Clostridium difficile infection: from colonization to cure

K Shields, RV Araujo-Castillo, TG Theethira… - Anaerobe, 2015 - Elsevier
Clostridium difficile infection (CDI) is increasingly prevalent, dangerous and challenging to
prevent and manage. Despite intense national and international attention the incidence of …